πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

719 results for β€œLI” Clear

  1. tirbanibulin

    KLISYRI S.A.

    TOPICAL FDA: approved Β· EMA: approved

    D06BX03
  2. tirelizumab

    NMPA: clinical trials

  3. tislelizumab

    TEVIMBRA BEONE MEDICINES AUS PTY LTD

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01FF09
  4. tislelizumab-jsgr

    TEVIMBRA

    SOLUTION FDA: approved

  5. tocilizumab

    ACTEMRA Hoffmann-La Roche

    INJECTION FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AC07
  6. tocilizumab-aazg

    TYENNE

    SUBCUTANEOUS FDA: approved

  7. tocilizumab-anoh

    AVTOZMA

    IV (INFUSION) FDA: approved

  8. tocilizumab-bavi

    TOFIDENCE

    INJECTION FDA: approved

  9. tolazoline hydrochloride

    PRISCOLINE

    INJECTION FDA: approved

  10. toripalimab

    ZYTORVI Dr Reddy''s Laboratories (Australia) Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01FF13
  11. toripalimab-tpzi

    LOQTORZI Coherus Oncology

    INJECTION FDA: approved

  12. trelagliptin succinate

    ZAFATEK

    PMDA: approved

  13. tremelimumab

    IMJUDO AstraZeneca

    EMA: approved Β· TGA: approved

    L01FX20
  14. tremelimumab-actl

    IMJUDO

    INTRAVENOUS FDA: approved

  15. trilaciclib dihydrochloride

    COSELA

    INTRAVENOUS FDA: approved

  16. triprolidine hydrochloride

    TRIPROLIDINE HYDROCHLORIDE

    ORAL FDA: approved

  17. triptolide

    NMPA: clinical trials

  18. triptorelin

    DECAPEPTYL Ferring Pharmaceuticals

    TGA: approved

  19. triptorelin pamoate

    TRELSTAR

    INTRAMUSCULAR FDA: approved

  20. troglitazone

    REZULIN

    ORAL FDA: approved

  21. tuvonralimab

    NMPA: clinical trials

  22. ublituximab

    BRIUMVI NEURAXPHARM AUSTRALIA PTY LIMITED

    EMA: approved Β· TGA: approved

    L04
  23. ublituximab-xiiy

    BRIUMVI TG THERAPEUTICS, INC.

    INTRAVENOUS FDA: approved

  24. ulinastatin

    NMPA: clinical trials

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources